Back

Longevity of seropositivity and neutralizing titers among SARS-CoV-2 infected individuals after 4 months from baseline: a population-based study in the province of Trento

Stefanelli, P.; Bella, A.; Fedele, G.; Fiore, S.; Pancheri, S.; Benedetti, E.; Fabiani, C.; Leone, P.; Vacca, P.; Schiavoni, I.; Neri, A.; Carannante, A.; Simmaco, M.; Santino, I.; Zuccali, M. G.; Bizzarri, G.; Magnoni, R.; Benetollo, P. P.; Brusaferro, S.; Rezza, G.; Ferro, A.

2020-11-13 infectious diseases
10.1101/2020.11.11.20229062 medRxiv
Show abstract

BackgroundThere are conflicting results about the duration of antibodies induced by SARS-CoV-2, but several studies show a rapid decay in a few months after infection. To evaluate antibody decline, we re-evaluated the presence of anti-SARS-CoV-2 antibodies among individuals found seropositive in a first population survey conducted 4 months before. MethodsAll individuals above ten years of age resident in 5 municipalities of the Autonomous Province of Trento, northern Italy, who resulted IgG positive for anti-SARS-CoV-2 nucleocapsid (NC) antibodies in a serosurvey conducted on May 2020 were retested after 4 months. Anti-SARS-CoV-2 antibodies were detected using the Abbott SARS-CoV-2 IgG assay (Abbott Diagnostics, USA) detecting anti-NC antibodies. Samples that gave a negative result were re-tested using the same test plus Liaison SARS-CoV-2 IgG assay (DiaSorin, Italy) to assess anti-spike (S) S1/S2 IgG antibodies. Seroprevalence was calculated as the proportion of positive people on the total number of tested. A neutralizing assay was performed on a subgroup of formerly positives sera using fifty-percent tissue culture infective dose (TCID50) as endpoint dilution to produce a cytopathic effect in 50% of inoculated Vero E6 cells culture. In all the analyses a p value < 0.05 were considered statistically significant. Statistical analysis was performed by STATA version 16.1 (STATA Corp., College Station, Texas, USA). FindingsOverall, 1159 out of 1402 initially anti-NC seropositive participants were enrolled in the study. Of them, 480 (41.1%) became seronegative for anti-NC IgG antibodies. When 479 negative sera were tested for anti-S IgG, 373 samples (77.9%) resulted positives. A functional neutralization assay was performed on 106 sera showing high concordance with anti-S antibodies positivity. InterpretationA decline of anti-NC IgG values was recorded 4 months after the first evaluation. Worth of note, a high proportion of anti-NC seronegative individuals were positive for anti-spike IgG antibodies, which appear to persist longer and to better correlate with neutralization activity.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Clinical Microbiology and Infection
60 papers in training set
Top 0.1%
10.0%
2
BMC Infectious Diseases
118 papers in training set
Top 0.1%
8.4%
3
The Journal of Infectious Diseases
182 papers in training set
Top 0.4%
6.8%
4
Journal of Medical Virology
137 papers in training set
Top 0.6%
4.3%
5
Infectious Diseases
14 papers in training set
Top 0.1%
4.1%
6
Eurosurveillance
80 papers in training set
Top 0.3%
3.9%
7
Journal of Clinical Virology
62 papers in training set
Top 0.1%
3.9%
8
Journal of Infection
71 papers in training set
Top 0.5%
3.6%
9
PLOS ONE
4510 papers in training set
Top 43%
2.9%
10
Scientific Reports
3102 papers in training set
Top 44%
2.7%
50% of probability mass above
11
Frontiers in Medicine
113 papers in training set
Top 2%
2.3%
12
Clinical Infectious Diseases
231 papers in training set
Top 2%
2.1%
13
Emerging Infectious Diseases
103 papers in training set
Top 1%
2.1%
14
Microorganisms
101 papers in training set
Top 0.5%
2.1%
15
BMJ Open
554 papers in training set
Top 8%
2.1%
16
International Journal of Infectious Diseases
126 papers in training set
Top 1%
1.9%
17
European Journal of Clinical Microbiology & Infectious Diseases
15 papers in training set
Top 0.1%
1.8%
18
The Lancet Infectious Diseases
71 papers in training set
Top 1%
1.8%
19
Nature Communications
4913 papers in training set
Top 50%
1.8%
20
The Lancet Microbe
43 papers in training set
Top 0.6%
1.7%
21
Microbiology Spectrum
435 papers in training set
Top 3%
1.7%
22
BMJ
49 papers in training set
Top 0.6%
1.7%
23
Journal of Clinical Virology Plus
10 papers in training set
Top 0.1%
1.7%
24
Epidemiology and Infection
84 papers in training set
Top 2%
1.2%
25
Viruses
318 papers in training set
Top 4%
1.1%
26
Open Forum Infectious Diseases
134 papers in training set
Top 2%
1.1%
27
Communications Medicine
85 papers in training set
Top 0.6%
0.9%
28
Annals of Internal Medicine
27 papers in training set
Top 0.9%
0.8%
29
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
30
European Respiratory Journal
54 papers in training set
Top 2%
0.8%